These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5633311)

  • 1. [Dynamics of serum lipid changes in patients with diffuse toxic goiter during treatment with I-131].
    Slukhaĭ IuF
    Med Radiol (Mosk); 1967 May; 12(5):67-9. PubMed ID: 5633311
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the hemodynamics of patients with toxic goiter following treatment with radioactive iodine (according to radiocardiographic findings)].
    Katsevman AE
    Med Radiol (Mosk); 1971 Nov; 16(11):36-40. PubMed ID: 4950000
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ballistocardiography in patients with diffuse toxic goiter during I-131 treatment].
    Dozorets IuL; Bogdanovich GI; Seleznev LE
    Med Radiol (Mosk); 1969 Aug; 14(8):41-4. PubMed ID: 5396104
    [No Abstract]   [Full Text] [Related]  

  • 4. [Late results of treatment of toxic goiter with radioactive iodine].
    Islambekov RK; Turakulov JC
    Cas Lek Cesk; 1968 Dec; 107(50):1525-9. PubMed ID: 4179749
    [No Abstract]   [Full Text] [Related]  

  • 5. [Radioactive iodine treatment of patients with relapsing toxic goiter].
    Iaroslavtsev SA
    Klin Med (Mosk); 1968 Sep; 46(9):106-10. PubMed ID: 5756042
    [No Abstract]   [Full Text] [Related]  

  • 6. Post-therapeutic thyroid reserve. Thyroid reserve in euthyroid patients after ablative therapy for diffuse toxic goiter.
    Prendergast JJ; Miller JM
    Henry Ford Hosp Med J; 1970; 18(1):3-10. PubMed ID: 5467196
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interrelationship of a glucose tolerance disorder and the lipid level in the blood in diffuse toxic goiter during the treatment process].
    Zaripova ZKh
    Sov Med; 1978 Jun; (6):56-9. PubMed ID: 580978
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dynamics of protein-bound iodine and iodine extracted with butanol in diffuse toxic goiter patients treated with radioactive iodine (I-131) after preliminary treatment with mercazolyl and reserpine].
    Anestiadi ZG
    Probl Endokrinol (Mosk); 1969; 15(1):6-10. PubMed ID: 4185484
    [No Abstract]   [Full Text] [Related]  

  • 9. [Toxic adenoma. Study of 35 cases].
    Barceló Lucerga B; Alcañiz Ferrando J; Ortiz Berrocal J; Salto Hernández L
    Rev Iber Endocrinol; 1971; 18(106):369-83. PubMed ID: 5171341
    [No Abstract]   [Full Text] [Related]  

  • 10. [Functional condition of the liver in patients with diffuse toxic goiter before and after treatment by I-131].
    Siesivieva VG; Shlevkov BA; Belousova ND
    Med Radiol (Mosk); 1966 May; 11(5):21-7. PubMed ID: 6014327
    [No Abstract]   [Full Text] [Related]  

  • 11. Thyroid gland suppressibility in patients treated with radioiodine for diffuse toxic goiter.
    Burgos FL; Micames C; Rivera JV
    Bol Asoc Med P R; 1983 Apr; 75(4):173-5. PubMed ID: 6575791
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in the content of electrolytes under the effect of radioiodine therapy of patients with diffuse toxic goiter in association with a severe form of thyrotoxicosis].
    Lipets AI; Dozorets IL
    Med Radiol (Mosk); 1971 Sep; 16(9):23-6. PubMed ID: 5172424
    [No Abstract]   [Full Text] [Related]  

  • 13. [Early hypothyroidism after I-131 treatment of hyperthyroidism: clinical detection].
    Wortsman J; Aguilera S; Dvoredsky A
    Rev Med Chil; 1972 Jun; 100(6):653-5. PubMed ID: 4678108
    [No Abstract]   [Full Text] [Related]  

  • 14. [Megakaryocytopoiesis and thrombocytopoiesis in patients with diffuse toxic goiter during the period of treatment with I-131].
    Piksanov ON; Bykhovskaia AM
    Med Radiol (Mosk); 1967 Jan; 12(1):82-5. PubMed ID: 5633100
    [No Abstract]   [Full Text] [Related]  

  • 15. [Remote results of the treatment of patients with toxic goiter by radioactive iodine (I-131)].
    Petrova MM; Kurbatova LI
    Probl Endokrinol Gormonoter; 1965; 11(3):52-6. PubMed ID: 5898801
    [No Abstract]   [Full Text] [Related]  

  • 16. Why not radioiodine therapy for toxic nodular goiter?
    Hamburger JI; Kadian G; Rossin HW
    Arch Intern Med; 1967 Jan; 119(1):75-9. PubMed ID: 6071164
    [No Abstract]   [Full Text] [Related]  

  • 17. I131 treatment for toxic diffuse goiter: analysis of 1056 cured cases.
    Yang HF; Chen FW; Chen CC
    Taiwan Yi Xue Hui Za Zhi; 1969 Feb; 68(2):94-105. PubMed ID: 5257435
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of thyrostatic preparations to reduce the radioresistance of toxic goiter during radioiodine treatment].
    Livergant IuE; Suslina NG
    Med Radiol (Mosk); 1968 Jul; 13(7):9-11. PubMed ID: 4190228
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term results with iodine-125 treatment for toxic diffuse goitre.
    Werner SC; Johnson PM; Goodwin PN; Wiener JD; Lindeboom GA
    Lancet; 1970 Oct; 2(7675):681-5. PubMed ID: 4195929
    [No Abstract]   [Full Text] [Related]  

  • 20. [Radioisotope therapy of hyperthyroidism].
    Englaro GC; Zecchin R
    Minerva Med; 1973 Apr; 64(25):1347-56. PubMed ID: 4740096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.